Site is under construction

en Association of HLA-DRA and IL2RA Polymorphisms with the Severity and Relapses Rate of Multiple Sclerosis in an Iranian Population زیست شناسی ملکولی Molecular Biology مقالات اصلی Original Article <div style="text-align: justify;">Background: Multiple sclerosis (MS) is a multifactorial condition in which many genetic and environmental factors interfere. The association between genes involved in the immune system and MS was previously reported. The aims of this study were to evaluate 14 SNPs of HLA-DRA, 14 SNPs of IL2RA with severity of MS through Expanded Disability Status Scale (EDSS) and Annualized Relapse Rate (ARR). Methods: 102 patients with MS referred to Sina hospital in Tehran, Iran, were diagnosed and studied based on McDonald’s guideline, clinical signs, and brain imaging procedures. All patients were included in the study following informed consent. Genotyping study of 14 variants in the HLA-DRA, and 14 variants in IL2RA was conducted by Sanger sequencing. Disease outcomes including EDSS and ARR were registered. Outcome measures between different genotypes of each SNPs were compared separately. Results: Among 14 SNPs in IL 2RA the genotypes of rs12722489 showed a significant association with ARR in two consecutive years. Mean ARR1 was 1.06±1.12, 0.20±0.34 and 0.31±.50 for AA, GA, and GG genotypes, respectively (p value= 0.008). Mean ARR2 was 1.5±1.08, 0.28±0.40, and 0.42±0.55 for AA, GA, and GG, respectively (p value= 0.001). Regression analysis showed a significant association between rs12722489 with ARR1 and ARR2, removing the potential confounding mediators. No significant association was found between SNPs in HLA-DRA with the attack rate and severity of MS. Conclusions: The rs12722489 of IL-2RA has an association with ARR, but not with EDSS.</div> Annualized Relapse Rate, Expanded Disability Status Scale, HLA, Multiple Sclerosis, SNP 129 139 http://rbmb.net/browse.php?a_code=A-10-425-1&slc_lang=en&sid=1 Mohsen Asouri 100319475328460017553 100319475328460017553 No Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran & North Research Center, Pasteur Institute of Iran, Amol, Iran Hamid Alinejad Rokni 100319475328460017554 100319475328460017554 No Systems Biology and Health Data Analytics Lab, the Graduate School of Biomedical Engineering, UNSW Sydney, 2052, NSW, AU Mohammad Ali Sahraian 100319475328460017555 100319475328460017555 No Multiple Sclerosis Research Center; Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran Sadegh Fattahi 100319475328460017556 100319475328460017556 No North Research Center, Pasteur Institute of Iran, Amol, Iran Nima Motamed 100319475328460017557 100319475328460017557 No Department of Social Medicine, Zanjan University of Medical Sciences, Zanjan, Iran Rozita Doosti 100319475328460017558 100319475328460017558 No Multiple Sclerosis Research Center; Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran Galia Amirbozorgi 100319475328460017559 100319475328460017559 No North Research Center, Pasteur Institute of Iran, Amol, Iran Morteza Karimpoor mortezakarimi@pasteur.ac.ir 100319475328460017560 100319475328460017560 Yes Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran Fereidoun Mahboudi 100319475328460017561 100319475328460017561 No Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran Haleh Akhavan-Niaki 100319475328460017562 100319475328460017562 No Zoonoses Research Center, North Research Center, Pasteur Institute of Iran, Amol, Iran & Department of Genetics, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran